Toralf Melsom Selected Research

Iohexol (Omnipaque)

1/2022	Serum matrix metalloproteinase 7 and accelerated glomerular filtration rate decline in a general non-diabetic population.
1/2019	Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians.
5/2018	Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline.
1/2018	Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline.
4/2017	Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.
2/2017	Blood pressure and age-related GFR decline in the general population.
11/2016	Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study.
2/2016	Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
1/2016	Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population.
1/2015	Estimated GFR is biased by non-traditional cardiovascular risk factors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toralf Melsom Research Topics

Disease

17	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 12/2010
10	Kidney Diseases (Kidney Disease) 10/2019 - 12/2010
5	Albuminuria 12/2022 - 01/2016
5	Chronic Renal Insufficiency 01/2021 - 01/2015
2	Ischemic Stroke 11/2018 - 07/2012
2	Diabetes Mellitus 01/2018 - 12/2010
1	Fibrosis (Cirrhosis) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Humeral Fractures 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Myocardial Infarction 11/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Isolated Systolic Hypertension 02/2017
1	Obesity 11/2016
1	Prediabetic State (Prediabetes) 01/2016
1	Hyperuricemia 01/2016
1	Insulin Resistance 01/2015
1	Neoplasms (Cancer) 07/2012
1	Hyperinsulinism (Hyperinsulinemia) 07/2011
1	Stroke (Strokes) 12/2010

Drug/Important Bio-Agent (IBA)

15	Iohexol (Omnipaque)FDA Link 01/2022 - 12/2010
13	CreatinineIBA 01/2021 - 12/2010
7	Cystatin CIBA 01/2021 - 12/2010
6	AlbuminsIBA 12/2022 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2011
2	HDL CholesterolIBA 08/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2017
1	Orosomucoid (Seromucoid)IBA 12/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Syndecan-4IBA 11/2018
1	Syndecan-1 (Syndecan 1)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 05/2018
1	8-hydroxyguanosineIBA 05/2018
1	8-Hydroxy-2'-DeoxyguanosineIBA 05/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 02/2017
1	Indicators and Reagents (Reagents)IBA 11/2016
1	Appetite Depressants (Anorectics)IBA 10/2016
1	Hexosaminidases (Hexosaminidase)IBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	AdiponectinIBA 01/2016
1	symmetric dimethylarginineIBA 01/2015
1	dimethylarginineIBA 01/2015
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2015
1	Arginine (L-Arginine)FDA Link 01/2015